维普中文期刊产品整合服务
27篇 您的检索式:作者名="PETRIOLI R"
    题名 作者 年代 出处 被引量
1Carboplatin, methotrex- ate, vinblastine, and epirubicin (M - VECa) as salvage treatment in patients with advanced bladder cancer: a phase I] study显示文摘Petrioli R Roviello G Fiaschi AI 2015Anticancer Drugs2015,26,8:1
2Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids显示文摘FRANCINI G PETRIOLI R MONTAGNANI A 2006Br J Cancer2006,17,2:1
3Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer:a randomised phase Ⅱ study显示文摘Petrioli R Pascucci A Conca R 2011Br J Cancer2011,104,4:1
4Weekly docetaxel and epirubicin in treatment of advanced honneone-refractory prostate cancer显示文摘Petrioli R Paolelli L Franeini E 2007Urology2007,69,1:1
5Weekly docetaxel and epirubicin in treatment of advanced hormone-refractory prostate cancer显示文摘Petrioli R Paolelli L Francini E 2007Urology2007,69,1:1
6Weekly low-dose docetaxel in advanced non-small cell lung cancer previously trea-ted with two chemotherapy regimens显示文摘Petrioli R Pozzessere D Messinese S 2003Lung Cancer2003,39,1:1
7The role of doxorubicin and epimbiein in the treatment of patients with metastatic hormonerefract- ory prostate cancer显示文摘Petrioli R Fiaschi A Francini E 2008Cancer Treat Rev2008,34,:1
8Sequential treatment with epirubi- cin, oxaliplatin and 5 FU (EOF) followed by docetaxel, oxaliplatin and 5FU(DOF) in patients with advanced gastric or gastroesophageal cancer: a single - institution experience 显示文摘Petrioli R Francini E Roviello F 2015Cancer Chemother Phar- maco12015,75,5:1
9Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin显示文摘Petrioli R Bargagli G Lazzi S 2010Anticancer Drugs2010,21,3:1
10Weekly high - dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel 显示文摘Petrioli R Pascucci A Francini E 2007BJU Int2007,100,4:1
11PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials显示文摘Francini E Petrioli R Rossi G 2014Tumour Biol2014,35,10:1
12Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis 显示文摘Petrioli R Roviello G Zanotti L 2016Crit Rev Oncol Hematol2016,102,:1
13FOLFOX-4 stop and go and capecitabine maintenance chemotherapy in the treatment of metastatic colorectal cancer显示文摘Petrioli R Paolelli L Marsili S 2006Oncology2006,70,:1
14Cisplatin,etoposide, and bevacizumab regimen followed by oral etoposide and bevacizumab maintenance treatment in patients with extensive-stage small cell lung cancer:a single-institution experience显示文摘Petrioli R Roviello G Laera L 2015Clin Lung Cancer2015,16,6:1
15Thymidine phosphorylase expression in metastatic sites is predictive for response in pa- tients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin显示文摘Petrioli R Bargagli G Lazzi S 2010Anti-Cancer Drugs2010,21,3:1
16Optimized packet size selection in underwater wireless sensor network communications 显示文摘Petrioli C Petroccia R Stojanovic M 2012IEEE Journal of Oceanic Engineering2012,37,3:1
17FOLFOX-4stop and go and capecitabine maintencance ch-emotherapy in the treatment of metastatic colorectal can-cer显示文摘Petrioli R Paolelli L Marsili S 2013Oncology2013,70,:1
18Weekly low-dose docetaxel in advanced hormone-resistant prostate cancer patients previously exposed to chemotherapy显示文摘Petrioli R Pozzessere D Messinese S 2003Oncology2003,64,4:1
19Weekly highdose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel显示文摘Petrioli R Pascucci A Francini E 2007BJU Int2007,29,:1
20Weekly docetaxel and epirubicin in treatment of advanced hormone-refractory prostate cancer显示文摘Petrioli R Paolelli L Franeini E 2007Urology2007,69,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费